Passive Leg Raising

2

Review clinical trials related to Passive Leg Raising. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effect of Systematic and Sequential Leg Elevation on Cardiac Output in Healthy Volunteers

Passive leg raising (PLR) transiently increases venous return and cardiac preload and is commonly used to predict fluid responsiveness in critically ill patients. Repeated fluid boluses contribute to fluid overload in septic shock, whereas PLR may provide similar hemodynamic effects without fluid administration. Before evaluating repeated PLR in septic shock patients, it is necessary to determine whether the cardiac output response to PLR remains present during repeated PLR maneuvers. SYSLE-1 is a prospective interventional physiological crossover study conducted in healthy volunteers. Participants will undergo six consecutive passive leg raising sessions performed either during spontaneous breathing or non-invasive ventilation, in randomized order. The study aims to determine whether the increase in cardiac output induced by the first PLR maneuver persists during repeated PLR sessions.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Régional d'OrléansUpdated: Oct 8, 2026Locations: 1
Eligibility criteria

Male or female participant. [+6]

Body mass index greater than 35 kg/m². [+10]

Status: Recruiting

Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy

The goal of this randomised controlled trial is to compare the cumulative fluid balance over the first 72 h following inclusion guided by mVExUS versus standard of care in critically ill patients with acute kidney injury receiving CRKT . It will also compare the proportion of CRRT-related complications-including intradialytic hypotension and arrhythmias-between patients managed with mVExUS-guided fluid management and those receiving standard care. The main questions it aims to answer are: Does fluid removal rate guided by mVExUS will reduce cumulative fluid balance over the course of the first 72 h of CRRT in ICU patients compared to standard care Participants will: Get fluid assessment by mVExUS protocol or a strandard care every 8 hours for 72 hours

Participants needed: 126
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Chulalongkorn UniversityUpdated: Oct 5, 2026Locations: 2
Eligibility criteria

Adults (≥ 18 years of age) [+7]

Refuse to participate [+13]